)
)
Organon Investor Relations Material
Latest events
Q3 2024
Organon
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Organon & Co
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe and Canada
U.S.
Asia Pacific and Japan
China
Other
Expenses by
Financials
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. The company operates under the Organon & Co. Pharmaceuticals and Organon brands. Its products include hormone contraceptives; biosimilars; women's health products consisting of fertility, menopause, contraception, osteoporosis and gynecological cancer; and treatments for psychiatric and neurological disorders comprising schizophrenia, bipolar mania disorder and depression. The company also offers food animal health products, including pain relief for horses, cattle and sheep; and anti-infectives for poultry.
Key slides for Organon & Co
Q3 2024
Organon & Co
Q3 2024
Organon & Co
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
OGN
Country
🇺🇸 United States